calcium dobesilate has been researched along with Diabetic Retinopathy in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (48.39) | 18.7374 |
| 1990's | 8 (12.90) | 18.2507 |
| 2000's | 8 (12.90) | 29.6817 |
| 2010's | 11 (17.74) | 24.3611 |
| 2020's | 5 (8.06) | 2.80 |
| Authors | Studies |
|---|---|
| An, X; Duan, L; Duan, Y; Kang, X; Lian, F; Zhang, Y; Zhou, R | 1 |
| Wang, D; Wang, H; Wu, S; Xu, J; Yang, X | 1 |
| Li, Y; Yao, L; Zhao, Z | 1 |
| Hu, H; Liu, J; Qiu, S; Song, Q; Sun, ZL; Wang, D; Wang, F; Wen, L; Yuan, Y | 1 |
| Akbari, M; Ashraf, H; Ghaffari, M; Jahanbani-Ardakani, H; Khalili, MR; Lotfi, M | 1 |
| Bogdanov, P; Garcia-Ramirez, M; Hernández, C; Pasquali, C; Sampedro, J; Simó, R; Solà-Adell, C; Valeri, M | 1 |
| Ambrósio, AF; Bauer, J; Cunha-Vaz, J; Leal, EC; Liberal, J; Santiago, AR; Voabil, P | 1 |
| Bogdanov, P; García-Ramírez, M; Hernández, C; Pasquali, C; Sampedro, J; Simó, R; Simó-Servat, O; Solà-Adell, C; Valeri, M | 1 |
| Cheng, X; Guo, X; Hou, L; Li, D; Qiu, L; Wang, D; Wu, J; Xia, L; Xu, E; Yin, Y; Zhao, F | 1 |
| Li, S; Liu, J; Sun, D | 1 |
| Bae, SH; Cho, H; Kim, HK; Moon, SW; Shin, YU | 1 |
| Cui, W; Lu, Q; Luo, D; Wang, J; Wang, X; Yang, W; Yu, X; Zhang, Q; Zheng, Y | 1 |
| Jin, J; Li, W; Liu, W; Wang, N; Wu, S; Zhang, X | 1 |
| Ballarini, S; Cunha-Vaz, J; Haller, H; Ji, L; Simó, R; Wong, TY; Zimmet, P | 1 |
| Einarsdóttir, AB; Stefánsson, E | 1 |
| Gerss, J; Haritoglou, C; Kampik, A; Sauerland, C; Ulbig, MW | 1 |
| Ambrósio, AF; Bauer, J; Chiavaroli, C; Cunha-Vaz, J; Leal, EC; Liberal, J; Martins, J; Voabil, P | 1 |
| Adl, FH; Andalib, D; Ghabili, K; Ghorbanihaghjo, A; Javadzadeh, A; Khojasteh-Jafari, H | 1 |
| Allain, H; Bentué-Ferrer, D; Polard, E; Ramelet, AA | 1 |
| Chiavaroli, C; Garay, RP; Hannaert, P; Rota, R | 1 |
| Chiavaroli, C; Garay, RP; Hannaert, P | 1 |
| Ahn, BO; Choi, SM; Chung, HK; Kim, JH; Kim, WB; Kwak, HH | 1 |
| Caillon, P; Carneiro, AM; Cunha-Vaz, JG; Ribeiro, ML; Seres, AI; Stur, M; Zourdani, A | 1 |
| Vojnikovic, B | 2 |
| Saldan, IR | 1 |
| Kulle, M; Zabel-Langhennig, R | 1 |
| Barras, JP; Graf, C | 2 |
| Eckhardt, M; Haas, A; Pfeiffer, KP; Schmut, O; Trummer, G; Uyguner, I | 1 |
| García Benayas, E; García Díaz, B; Pérez, G | 1 |
| Guo, L; Zhong, H | 1 |
| Barras, JP; Berthet, P; Farine, JC | 1 |
| Berta, A; Chiavaroli, C; Farine, JC; Garay, E; Garay, RP; Haines, D; Hannaert, P; Szabo, ME | 1 |
| Bisceglia, H; Elizalde, F; Nano, H; Pérez, H; Salama Benarroch, I; Salama, A | 1 |
| Daubresse, JC; Dumont, P; Meunier, R | 1 |
| Hoppe, R; Larsen, HW; Sander, E | 1 |
| Aronson, SB; Becker, B; Cavender, JC; Cleasby, GW; Fung, WE; Smith, ME; Stamper, RL | 1 |
| Karel, I | 1 |
| Fossati, C | 1 |
| Dittmar, P | 1 |
| De Courten, A; Sevin, R | 1 |
| Sévin, R | 2 |
| Egerer, I; Freyler, H | 1 |
| Binkhorst, PG; Van Bijsterveld, OP | 1 |
| Kutschera, E | 1 |
| Bryk, E; Maciejewski, Z; Pasadyn, J; Szopińska-Cibowa, L; Zygulska-Machowa, H | 1 |
| Teuscher, A | 1 |
| Cuendet, JF; Sevin, R | 1 |
| Reuter, H | 1 |
| Meyer, JP; Rintelen, F | 1 |
| Farkas, A; Hudomel, J; Németh, B | 1 |
| Zielinski, HW | 1 |
| Cunha-Vaz, JG; de Abreu, JR; Leite, EB; Mota, MC | 1 |
| Hachen, HJ; Vinazzer, H | 1 |
| Barras, JP; Michal, M | 1 |
| Adank, C; Koerner, F | 1 |
| Benarroch, IS; Brodsky, M; Rubinstein, A; Salama, EA; Viggiano, C | 1 |
10 review(s) available for calcium dobesilate and Diabetic Retinopathy
| Article | Year |
|---|---|
Effect of Chinese Patent Medicines on Ocular Fundus Signs and Vision in Calcium Dobesilate-Treated Persons With Non-Proliferative Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
Topics: Calcium Dobesilate; China; Diabetes Mellitus; Diabetic Retinopathy; Drugs, Chinese Herbal; Humans; Nonprescription Drugs | 2022 |
Intravitreal Ranibizumab Alone or in Combination with Calcium Dobesilate for the Treatment of Diabetic Macular Edema in Nonproliferative Diabetic Retinopathy Patients: 12-Month Outcomes of a Retrospective Study.
Topics: Angiogenesis Inhibitors; Calcium Dobesilate; Case-Control Studies; Diabetes Mellitus; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Observational Studies as Topic; Ranibizumab; Retrospective Studies; Treatment Outcome | 2022 |
Calcium Dobesilate and Micro-vascular diseases.
Topics: Animals; Antioxidants; Calcium Dobesilate; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Microvessels; Oxidative Stress; Vascular Diseases | 2019 |
Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis.
Topics: Calcium Dobesilate; Diabetic Retinopathy; Humans | 2015 |
Non-traditional systemic treatments for diabetic retinopathy: an evidence-based review.
Topics: Animals; Calcium Dobesilate; Diabetic Retinopathy; Fenofibrate; Humans; Renin-Angiotensin System | 2015 |
Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.
Topics: Animals; Calcium Dobesilate; Chronic Disease; Clinical Trials as Topic; Diabetic Retinopathy; Hemorrhoids; Hemostatics; Humans; Product Surveillance, Postmarketing; Venous Insufficiency | 2004 |
[Diabetic retinopathy].
Topics: Calcium Dobesilate; Diabetic Retinopathy; Diathermy; Ethamsylate; Humans; Hypophysectomy; Light Coagulation; Methods; Rutin | 1978 |
[Therapy of diabetic retinopathy].
Topics: Anabolic Agents; Anticoagulants; Ascorbic Acid; Calcium Dobesilate; Clofibrate; Cryosurgery; Diabetic Retinopathy; Humans; Hypoglycemic Agents; Hypophysectomy; Light Coagulation; Salivary Glands; Sclera | 1979 |
[Calcium dobesilate].
Topics: Adult; Aged; Animals; Benzenesulfonates; Calcium Dobesilate; Clinical Trials as Topic; Diabetic Angiopathies; Diabetic Retinopathy; Female; Humans; Lethal Dose 50; Mice; Middle Aged; Pregnancy; Pregnancy Complications, Cardiovascular; Protein Binding; Rabbits; Rats; Time Factors; Varicose Veins; Vascular Diseases; Venous Insufficiency | 1975 |
Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review.
Topics: Benzenesulfonates; Blood Viscosity; Calcium Dobesilate; Diabetic Angiopathies; Diabetic Retinopathy; Erythrocyte Aggregation; Erythrocytes; Humans; Microcirculation | 1986 |
19 trial(s) available for calcium dobesilate and Diabetic Retinopathy
| Article | Year |
|---|---|
Calcium hydroxybenesulfonate improves vascular proliferation in patients with diabetic retinopathy via reducing VEGF, CAM-1 and MMP-9.
Topics: Aged; Calcium Dobesilate; Cell Adhesion Molecule-1; Diabetic Retinopathy; Female; Hemostatics; Humans; Male; Matrix Metalloproteinase 9; Middle Aged; Retinal Neovascularization; Vascular Endothelial Growth Factor A | 2021 |
Efficacy of calcium dobesilate in treating Chinese patients with mild-to-moderate non-proliferative diabetic retinopathy (CALM-DR): protocol for a single-blind, multicentre, 24-armed cluster-randomised, controlled trial.
Topics: Calcium Dobesilate; China; Diabetes Mellitus; Diabetic Retinopathy; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Retinal Vessels; Single-Blind Method | 2021 |
Effect of grape seed proanthocyanidin extract on hard exudates in patients with non-proliferative diabetic retinopathy.
Topics: Administration, Oral; Aged; Calcium Dobesilate; Diabetic Retinopathy; Double-Blind Method; Exudates and Transudates; Female; Grape Seed Extract; Hemostatics; Humans; Male; Middle Aged; Proanthocyanidins; Severity of Illness Index; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2019 |
Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
Topics: Adult; Aged; Analysis of Variance; Calcium Dobesilate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Double-Blind Method; Female; Fluorescein Angiography; Follow-Up Studies; Hemostatics; Humans; Kaplan-Meier Estimate; Logistic Models; Macular Edema; Male; Middle Aged; Proportional Hazards Models; Risk Reduction Behavior; Severity of Illness Index; Time Factors | 2009 |
Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy.
Topics: Aged; C-Reactive Protein; Calcium Dobesilate; Diabetic Retinopathy; Double-Blind Method; Endothelin-1; Female; Hemostatics; Humans; Lipids; Male; Middle Aged; Retinal Vessels | 2013 |
Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
Topics: Adult; Aged; Blood-Retinal Barrier; Calcium Dobesilate; Capillary Permeability; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Double-Blind Method; Female; Fluorescein; Fluorescein Angiography; Fluorophotometry; Hemostatics; Humans; Male; Middle Aged; Pilot Projects; Visual Acuity; Vitreous Body | 2006 |
Hyperviscosity in whole blood, plasma, and aqueous humor decreased by doxium (calcium dobesilate) in diabetics with retinopathy and glaucoma: a double-blind controlled study.
Topics: Adult; Aged; Aqueous Humor; Benzenesulfonates; Blood Viscosity; Calcium Dobesilate; Clinical Trials as Topic; Diabetes Complications; Diabetic Retinopathy; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Random Allocation; Visual Acuity | 1984 |
[Effect of calcium dobesilate on progression of diabetic retinopathy].
Topics: Adult; Aged; Blood Viscosity; Calcium Dobesilate; Contrast Sensitivity; Diabetic Retinopathy; Erythrocyte Deformability; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Visual Fields | 1995 |
Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation.
Topics: Benzenesulfonates; Calcium Dobesilate; Capillary Fragility; Capillary Permeability; Clinical Trials as Topic; Diabetic Retinopathy; Drug Evaluation; Humans; Placebos; Retinal Hemorrhage; Visual Acuity | 1977 |
A controlled clinical trial of calcium dobesylate in the treatment of diabetic retinopathy.
Topics: Benzenesulfonates; Calcium Dobesilate; Capillary Resistance; Clinical Trials as Topic; Diabetic Retinopathy; Female; Humans; Insulin; Male; Middle Aged; Placebos; Retinal Hemorrhage | 1977 |
The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial.
Topics: Adult; Aged; Benzenesulfonates; Calcium Dobesilate; Capillary Resistance; Clinical Trials as Topic; Diabetic Retinopathy; Female; Fluorescein Angiography; Humans; Male; Middle Aged; Radiography | 1977 |
The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
Topics: Adult; Aneurysm; Benzenesulfonates; Calcium Dobesilate; Capillary Fragility; Clinical Trials as Topic; Diabetic Retinopathy; Double-Blind Method; Exudates and Transudates; Fluorescein Angiography; Humans; Placebos; Radiography; Retinal Hemorrhage; Retinal Vessels | 1978 |
[Treatment of the diabetic retinopathy with doxium-clofibrate (author's transl)].
Topics: Adult; Aged; Benzenesulfonates; Calcium Dobesilate; Clinical Trials as Topic; Clofibrate; Diabetic Retinopathy; Drug Evaluation; Drug Therapy, Combination; Fluorescein Angiography; Humans; Middle Aged | 1976 |
Calcium dobesilate versus placebo in the treatment of diabetic retinopathy: a double-blind cross-over study.
Topics: Benzenesulfonates; Calcium Dobesilate; Clinical Trials as Topic; Diabetic Retinopathy; Female; Fluorescein Angiography; Humans; Male; Placebos; Radiography | 1976 |
[Calcium dobesilate].
Topics: Adult; Aged; Animals; Benzenesulfonates; Calcium Dobesilate; Clinical Trials as Topic; Diabetic Angiopathies; Diabetic Retinopathy; Female; Humans; Lethal Dose 50; Mice; Middle Aged; Pregnancy; Pregnancy Complications, Cardiovascular; Protein Binding; Rabbits; Rats; Time Factors; Varicose Veins; Vascular Diseases; Venous Insufficiency | 1975 |
Doxium (calcium dobesilate) reduces blood hyperviscosity and lowers elevated intraocular pressure in patients with diabetic retinopathy and glaucoma.
Topics: Administration, Oral; Blood Viscosity; Calcium Dobesilate; Diabetic Retinopathy; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Retinal Hemorrhage; Visual Acuity; Visual Fields | 1991 |
Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.
Topics: Analysis of Variance; Benzenesulfonates; Blood-Retinal Barrier; Calcium Dobesilate; Diabetic Retinopathy; Double-Blind Method; Female; Fluorophotometry; Follow-Up Studies; Humans; Male; Middle Aged; Permeability; Randomized Controlled Trials as Topic; Vitreous Body | 1990 |
Influence of calcium dobesilate (Doxium) on blood viscosity and coagulation parameters in diabetic retinopathy.
Topics: Benzenesulfonates; Blood Coagulation; Blood Viscosity; Calcium Dobesilate; Clinical Trials as Topic; Diabetic Retinopathy; Double-Blind Method; Female; Humans; Male; Middle Aged | 1987 |
Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy.
Topics: Adult; Aged; Benzenesulfonates; Blood Viscosity; Calcium Dobesilate; Cholesterol; Diabetic Retinopathy; Double-Blind Method; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Serum Albumin; Serum Globulins | 1985 |
34 other study(ies) available for calcium dobesilate and Diabetic Retinopathy
| Article | Year |
|---|---|
Effect of calcium dobesilate on retrobulbar blood flow and choroidal thickness in patients with non-proliferative diabetic retinopathy.
Topics: Adult; Aged; Blood Flow Velocity; Calcium Dobesilate; Ciliary Arteries; Diabetes Mellitus; Diabetic Retinopathy; Humans; Middle Aged; Ophthalmic Artery; Regional Blood Flow; Retinal Artery; Ultrasonography, Doppler, Color | 2021 |
Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes.
Topics: Animals; Apoptosis; Blotting, Western; Calcium Dobesilate; Cell Survival; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Electroretinography; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hemostatics; Humans; In Situ Nick-End Labeling; Male; Mice; Microscopy, Fluorescence; Oxidative Stress; Real-Time Polymerase Chain Reaction; Retina; Retinal Pigment Epithelium; RNA; Vascular Endothelial Growth Factor A | 2017 |
Calcium Dobesilate Is Protective against Inflammation and Oxidative/Nitrosative Stress in the Retina of a Type 1 Diabetic Rat Model.
Topics: Animals; Apoptosis; Blood-Retinal Barrier; Calcium Dobesilate; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Hemostatics; Inflammation; Male; Oxidative Stress; Rats; Rats, Wistar; Retina | 2017 |
Calcium dobesilate prevents the oxidative stress and inflammation induced by diabetes in the retina of db/db mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biomarkers; Calcium Dobesilate; Cells, Cultured; Crosses, Genetic; Cytokines; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; I-kappa B Kinase; Male; Mice, Mutant Strains; Mice, Transgenic; Neuroprotective Agents; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Random Allocation; Retina; Retinitis | 2017 |
Calcium dobesilate: A drug treatment for diabetic retinopathy can negatively interfere with the measurement of glycated albumin using the enzymatic method.
Topics: Administration, Oral; Adult; Artifacts; Blood Chemical Analysis; Calcium Dobesilate; Diabetic Retinopathy; Enzymes; Female; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Serum Albumin; Young Adult | 2018 |
Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Topics: Animals; Anticoagulants; Calcium Dobesilate; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Fluorescein Angiography; Fluorescent Antibody Technique, Indirect; Hemostatics; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Molecular Weight; Polysaccharides; Real-Time Polymerase Chain Reaction; Retina; Retinal Neovascularization; Retinal Vessels; Vascular Endothelial Growth Factor A | 2013 |
Prevention of diabetic retinopathy.
Topics: Calcium Dobesilate; Carbonic Anhydrase Inhibitors; Diabetic Retinopathy; Disease Progression; Fluorescein Angiography; Hemostatics; Humans; Macular Edema; Randomized Controlled Trials as Topic; Risk Reduction Behavior | 2009 |
Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes.
Topics: Animals; Blood-Brain Barrier; Calcium Dobesilate; Cell Adhesion; Claudin-5; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Endothelium; Hemostatics; Leukocytes; Male; Membrane Proteins; Occludin; Permeability; Phosphoproteins; Rats; Rats, Wistar; Retina; Tight Junctions; Zonula Occludens-1 Protein | 2010 |
Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
Topics: Albumins; Animals; Antioxidants; Blood-Retinal Barrier; Calcium Dobesilate; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glycation End Products, Advanced; Hemostatics; Immunohistochemistry; Lysine; Male; Rats; Rats, Wistar; Retina; Vascular Endothelial Growth Factor A | 2004 |
Calcium dobesilate in the treatment of diabetic retinopathy.
Topics: Animals; Antioxidants; Blood-Retinal Barrier; Calcium Dobesilate; Diabetic Retinopathy; Evidence-Based Medicine; Humans; Oxidative Stress; Rats | 2005 |
Efficacy of troxerutin on streptozotocin-induced rat model in the early stage of diabetic retinopathy.
Topics: Animals; Apyrase; Blood Glucose; Body Weight; Calcium Dobesilate; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Fundus Oculi; Hemostatics; Hydroxyethylrutoside; Phytotherapy; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA; Vaccinium myrtillus; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents | 2005 |
[Use of disaggregants in treating diabetic retinopathy].
Topics: Ascorbic Acid; Aspirin; Calcium Dobesilate; Diabetic Angiopathies; Diabetic Retinopathy; Dipyridamole; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Humans; Pentoxifylline; Platelet Aggregation; Rutin; Thrombelastography; Vision, Ocular | 1984 |
[Capillary fragility in diabetics and its modification by calcium dobesilate].
Topics: Adolescent; Adult; Aged; Benzenesulfonates; Calcium Dobesilate; Capillary Fragility; Diabetic Angiopathies; Diabetic Retinopathy; Female; Humans; Male; Middle Aged; Vascular Resistance | 1983 |
Effects of medication on blood and plasma viscosity in diabetic subjects with retinopathy.
Topics: Benzenesulfonates; Blood Proteins; Blood Viscosity; Calcium Dobesilate; Diabetic Retinopathy; Fibrinogen; Hematocrit; Humans | 1981 |
Hyperviscosity in diabetic retinopathy treated with Doxium (calcium dobesilate).
Topics: Adult; Aged; Benzenesulfonates; Blood Viscosity; Calcium Dobesilate; Depression, Chemical; Diabetic Retinopathy; Female; Humans; Male; Middle Aged; Plasma; Time Factors | 1980 |
[Focusing on diabetic retinopathy].
Topics: Calcium Dobesilate; Diabetic Retinopathy; Fluorophotometry; Humans; Laser Coagulation | 1995 |
Calcium dobesilate-induced agranulocytosis.
Topics: Agranulocytosis; Calcium Dobesilate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Hemostatics; Humans; Male; Middle Aged | 1997 |
[Early initiation recommended: calcium dobesilate in diabetic retinopathy].
Topics: Calcium Dobesilate; Diabetic Retinopathy; Dose-Response Relationship, Drug; Humans; Time Factors | 1998 |
[The plasma levels of endothelin in diabetic retinopathy and their changes after treatment with doxium].
Topics: Adult; Aged; Calcium Dobesilate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Endothelins; Female; Hemostatics; Humans; Male; Middle Aged | 1997 |
Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy.
Topics: Animals; Antioxidants; Calcium Dobesilate; Capillary Permeability; Diabetic Retinopathy; Hemostatics; Humans; Rats; Retinal Vessels; Visual Acuity | 1999 |
Antioxidant properties of calcium dobesilate in ischemic/reperfused diabetic rat retina.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Ca(2+) Mg(2+)-ATPase; Calcium; Calcium Dobesilate; Cations; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Free Radicals; Glutathione; Glutathione Disulfide; Magnesium; Male; Potassium; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Retina; Sodium; Sodium-Potassium-Exchanging ATPase | 2001 |
[Effect of calcium dobesilate on blood hyperviscosity].
Topics: Benzenesulfonates; Blood Viscosity; Calcium Dobesilate; Diabetic Retinopathy; Female; Humans; Male | 1979 |
[Photocoagulation given additional benefit by calciumdobesilate (author's transl)].
Topics: Adult; Aged; Benzenesulfonates; Calcium Dobesilate; Diabetic Retinopathy; Evaluation Studies as Topic; Female; Humans; Light Coagulation; Male; Middle Aged | 1979 |
Diabetic retinopathy and long-term therapy with Doxium 52 patients treated over periods ranging from 5--9 years.
Topics: Benzenesulfonates; Calcium Dobesilate; Diabetic Retinopathy; Female; Humans; Male; Middle Aged; Time Factors | 1978 |
[Long term treatment of diabetic retinopathy with doxium].
Topics: Adolescent; Adult; Benzenesulfonates; Calcium Dobesilate; Diabetic Retinopathy; Drug Evaluation; Humans | 1978 |
[Current dimensions of ophthalmology].
Topics: Adult; Aged; Calcium Dobesilate; Cataract; Cataract Extraction; Diabetic Retinopathy; Eye Diseases; Fluorescein Angiography; Fundus Oculi; Glaucoma; Humans; Light Coagulation; Middle Aged; Retinal Diseases | 1977 |
[Therapeutical action of Doxium (calcium-dobesilate) in diabetic retinopathy].
Topics: Adult; Aged; Benzenesulfonates; Calcium Dobesilate; Diabetic Retinopathy; Drug Evaluation; Female; Humans; Male; Middle Aged | 1976 |
[Correlations between clinical findings and therapeutic measures and the course of diabetic retinopathy].
Topics: Blood Glucose; Blood Pressure; Calcium Dobesilate; Diabetic Retinopathy; Flavonoids; Growth Hormone; Humans; Hypophysectomy; Insulin; Light Coagulation; Lipid Metabolism | 1976 |
What is new about the treatment of diabetic retinopathy by calcium dobesilae (Doxium).
Topics: Benzenesulfonates; Calcium Dobesilate; Capillary Fragility; Capillary Permeability; Diabetic Retinopathy; Humans | 1976 |
[5 years experimentation with calcium dobesilate in the treatment of retinopathies].
Topics: Benzenesulfonates; Calcium Dobesilate; Capillary Permeability; Capillary Resistance; Diabetic Retinopathy; Evaluation Studies as Topic; Humans; Stimulation, Chemical | 1975 |
[Sound and unsound drug therapy in diabetic retinopathy].
Topics: Anthocyanins; Calcium Dobesilate; Capillary Permeability; Capillary Resistance; Diabetic Retinopathy; Humans; Vitamin E | 1975 |
Effect of calcium bodesilate (doxium) on circulatory disorders of the retina with special emphasis on diabetic retinopathy.
Topics: Adolescent; Adult; Benzenesulfonates; Calcium Dobesilate; Depression, Chemical; Diabetic Retinopathy; Female; Fluorescein Angiography; Fundus Oculi; Humans; Male; Middle Aged; Retinal Diseases; Retinal Vessels; Vascular Resistance; Visual Acuity | 1975 |
[The diabetic retinopathy in the ophthalmologic practice (author's transl)].
Topics: Adult; Aged; Calcium Dobesilate; Diabetic Retinopathy; Drug Evaluation; Female; Fundus Oculi; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged | 1975 |
Calcium dobesilate in diabetic retinopathy. A retrospective controlled study.
Topics: Adolescent; Adult; Aged; Aneurysm; Benzenesulfonates; Calcium Dobesilate; Diabetic Retinopathy; Drug Evaluation; Exudates and Transudates; Female; Humans; Macular Degeneration; Male; Middle Aged; Random Allocation; Retinal Hemorrhage; Retrospective Studies; Visual Acuity | 1985 |